Discover
ADPT
Adaptive Biotechnologies Corporation
22.58
1 x 22.13
1 x 22.75
bid
ask
+
0.72
3.29%
25 @ 04:00 PM
22.19 -0.39 (1.75%)
| Ytd | 39.04% | |
| 1y | 119.01% |
20.90
day range
22.60
9.96
52 week range
23.15
| Open | 21.63 | Prev Close | 21.86 | Low | 20.90 | High | 22.60 | Mkt Cap | 3.61B |
| Vol | 3.51M | Avg Vol | 2.65M | EPS | -0.54 | P/E | -41.81 | Forward P/E | -83.29 |
| Beta | 2.07 | Short Ratio | 2.91 | Inst. Own | 96.15% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-29 | 50-d Avg | 17.71 | 200-d Avg | 16.28 | 1yr Est | 22.00 |
| Income Statement | |||
| Total Revenue | 70.87M | ||
| Revenues (USD) | 70.87M | ||
| Cost of Revenue | 18.71M | ||
| Gross Profit | 52.17M | ||
| Operating Expenses | 71.37M | ||
| Research and Development Expense | 23.62M | ||
| Selling, General and Administrative Expense | 47.33M | ||
| Operating Income | -19.21M | ||
| Interest Expense | 2.89M | ||
| Net Income | -20.03M | ||
| Net Income Common Stock | -20.03M | ||
| Net Income Common Stock (USD) | -20.03M | ||
| Consolidated Income | -20.01M | ||
| Net Income to Non-Controlling Interests | 18.00K | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -17.14M | ||
| Earning Before Interest & Taxes (USD) | -17.14M | ||
| Weighted Average Shares | 155.52M | ||
| Weighted Average Shares Diluted | 155.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 80.29M | ||
| Cash and Equivalents (USD) | 80.29M | ||
| Investments | 159.64M | ||
| Investments Current | 140.75M | ||
| Investments Non-Current | 18.89M | ||
| Trade and Non-Trade Receivables | 48.32M | ||
| Current Assets | 291.81M | ||
| Property, Plant & Equipment Net | 71.02M | ||
| Total Assets | 505.94M | ||
| Debt Current | 14.32M | ||
| Total Debt | 208.18M | ||
| Current Liabilities | 87.01M | ||
| Debt Non-Current | 193.86M | ||
| Total Liabilities | 281.70M | ||
| Accumulated Retained Earnings (Deficit) | -1.38B | ||
| Accumulated Other Comprehensive Income | -28.00K | ||
| Shareholders Equity | 216.34M | ||
| Shareholders Equity (USD) | 216.34M | ||
| Assets Non-Current | 214.14M | ||
| Total Debt (USD) | 208.18M | ||
| Deferred Revenue | 50.20M | ||
| Goodwill and Intangible Assets | 120.28M | ||
| Inventory | 11.21M | ||
| Liabilities Non-Current | 194.69M | ||
| Trade and Non-Trade Payables | 9.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.29M | ||
| Net Cash Flow from Financing | 7.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.11M | ||
| Capital Expenditure | -796.00K | ||
| Issuance (Purchase) of Equity Shares | 5.03M | ||
| Net Cash Flow from Investing | 9.14M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 9.94M | ||
| Net Cash Flow from Operations | -9.54M | ||
| Share Based Compensation | 11.93M | ||